Add this result to my export selection What are the benefits and harms of exercise for women with dysmenorrhea? Source: Cochrane Clinical Answers (Remove filter) 27 December 2019 Question: What are the benefits and harms of exercise for women with dysmenorrhea? Carlos Fernando Grillo‐Ardila... Type: Systematic Reviews (Remove filter)
Add this result to my export selection Acupuncture in patients with dysmenorrhea: a randomized study on clinical effectiveness and cost-effectiveness in usual care Source: NHS Economic Evaluation Database - NHS EED (Remove filter) 02 March 2009 Acupuncture in patients with dysmenorrhea: a randomized study on clinical effectiveness and cost-effectiveness in usual care Read Summary Type: Economic Evaluations (Remove filter)
Add this result to my export selection For adults with acute pain, what are the benefits and harms of caffeine as an analgesic adjuvant? Source: Cochrane Clinical Answers (Remove filter) 16 November 2017 maximum possible pain relief, 6 hours ‐ Dysmenorrhea Narrative result One RCT with 620 participants with dysmenorrhea found... Type: Systematic Reviews (Remove filter)
Add this result to my export selection What are the benefits and harms of mifepristone in women with endometriosis? Source: Cochrane Clinical Answers (Remove filter) 24 November 2017 reveals that mifepristone (2.5, 5, or 10 mg daily for 6 months) decreased dysmenorrhea (on average, 51 vs 402 per 1000 women) and... Type: Systematic Reviews (Remove filter)
Add this result to my export selection The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis Source: NHS Economic Evaluation Database - NHS EED (Remove filter) 30 April 2004 NSAIDs were widely prescribed to patients with conditions as diverse as dysmenorrhoea, acute pain episodes, lower-back pain, rheumatoid... Read Summary Type: Economic Evaluations (Remove filter)
Add this result to my export selection What are the benefits and harms of treatments for pain and subfertility in women with endometriosis? Source: Cochrane Clinical Answers (Remove filter) 05 December 2016 One systematic review reported no apparent difference between groups in dysmenorrhea at 6 or 12 months when laparoscopic surgery was... Type: Systematic Reviews (Remove filter)
Add this result to my export selection Can non‐contraceptive estrogen‐progestogen‐containing preparations control symptoms of premenstrual syndrome? Source: Cochrane Clinical Answers (Remove filter) 02 October 2017 (bleeding problems, breast tenderness, headache, nausea, weight gain, dysmenorrhea, or skin reactions) in women receiving estrogen plus... Type: Systematic Reviews (Remove filter)
Add this result to my export selection For women with heavy menstrual bleeding, how do antifibrinolytics compare with placebo? Source: Cochrane Clinical Answers (Remove filter) 23 August 2018 gastrointestinal effects, headache, uterine cancer, vaginal dryness, dysmenorrhea, thromboembolic events, or anemia. Most of the events... Type: Systematic Reviews (Remove filter)
Add this result to my export selection For women with heavy menstrual bleeding, how does tranexamic acid (TXA) compare with progestogens? Source: Cochrane Clinical Answers (Remove filter) 23 August 2018 assessed (gastrointestinal, vertigo, headache, bleeding, breast tenderness, dysmenorrhea, weight gain, allergic reaction, giddiness,... Type: Systematic Reviews (Remove filter)
Add this result to my export selection For women with heavy bleeding or pain associated with intrauterine device (IUD) use, how do non‐steroidal anti‐inflammatory drugs (NSAIDs) compare with placebo, each other, or alternative analgesics? Source: Cochrane Clinical Answers (Remove filter) 06 February 2020 versus placebo Expand All OUTCOME 1.1 IUD removal by 26 weeks for dysmenorrhea or increased menstrual blood loss Narrative result One... Type: Systematic Reviews (Remove filter)